Schrodinger is trading 10.70% up now at $19.56, with no clearly reported company-specific catalyst identified for August 19, 2026.
- Investors may still be digesting the August 5 earnings beat and improved profitability.
- Bristol Myers Squibb’s Bunsen AI collaboration may also remain in focus.
- Available coverage does not establish those earlier developments as the direct cause of this session’s move.